SpineAlign Medical Inc. announced today that it has chosen a new
trademark name, VerteLift, for its vertebral implant system. Formerly
called the SpineAlign System, the name reflects the advantages of the
product that the Company will leverage going forward.
The VerteLift System is designed for the treatment of vertebral
compression fractures and features an innovative nitinol implant,
designed to achieve vertebral body reconstruction via a transpedicular,
minimally invasive approach.
The VerteLift System represents the first of many new innovations in the
area of minimally invasive percutaneous vertebral body reconstruction to
come from SpineAlign Medical. The VerteLift device is a vertebral body
implant designed to treat fractures in the thoracic or lumbar spine in
patients suffering from osteoporosis. The VerteLift Implant is an
expandable metal device composed of a nickel-titanium (nitinol) alloy
that provides internal scaffolding to engage the vertebral body
endplates, maintaining lift until bone cement is injected. VerteLift is
available in two shapes and a range of sizes to address different
anatomical needs for the treatment of vertebral compression fractures.
Bone cement provides the long-term load bearing support. Prior to
injection of bone cement, the VerteLift Implant is fully retrievable for
repositioning or complete removal. The VerteLift System is not yet
available for sale in the United States and is currently in clinical
evaluation intended to support its 510(k) filing with the FDA. The
VerteLift System is in commercial distribution in Europe.
SpineAlign Medical, Inc.,